SE7510790L - Forfarande for framstellning av 2- eller 3-cefemderivat - Google Patents

Forfarande for framstellning av 2- eller 3-cefemderivat

Info

Publication number
SE7510790L
SE7510790L SE7510790A SE7510790A SE7510790L SE 7510790 L SE7510790 L SE 7510790L SE 7510790 A SE7510790 A SE 7510790A SE 7510790 A SE7510790 A SE 7510790A SE 7510790 L SE7510790 L SE 7510790L
Authority
SE
Sweden
Prior art keywords
procedure
preparation
cefem derivatives
cefem
derivatives
Prior art date
Application number
SE7510790A
Other languages
Unknown language ( )
English (en)
Other versions
SE434838B (sv
Inventor
T Kamiya
O Nakaguti
H Nakamura
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of SE7510790L publication Critical patent/SE7510790L/sv
Publication of SE434838B publication Critical patent/SE434838B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04—Preparation
SE7510790A 1971-09-09 1975-09-25 Forfarande for framstellning av ett oxiderat penamderivat SE434838B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7001871A JPS557433B2 (sv) 1971-09-09 1971-09-09

Publications (2)

Publication Number Publication Date
SE7510790L true SE7510790L (sv) 1975-09-25
SE434838B SE434838B (sv) 1984-08-20

Family

ID=13419434

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7510790A SE434838B (sv) 1971-09-09 1975-09-25 Forfarande for framstellning av ett oxiderat penamderivat

Country Status (3)

Country Link
JP (1) JPS557433B2 (sv)
ES (1) ES432975A1 (sv)
SE (1) SE434838B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4891087A (sv) * 1972-03-02 1973-11-27
JPS5661386A (en) * 1979-10-11 1981-05-26 Leo Pharm Prod Ltd Manufacture of penicillanic acid derivative
JPS6141943A (ja) * 1984-08-03 1986-02-28 Ube Kagaku Kogyo Kk ダストまたはダスト及び蒸気の多いガス用のガスサンプリング装置
US20190293521A1 (en) * 2016-11-11 2019-09-26 Biosurgical S.L. Filtration apparatus

Also Published As

Publication number Publication date
JPS4834192A (sv) 1973-05-16
JPS557433B2 (sv) 1980-02-25
SE434838B (sv) 1984-08-20
ES432975A1 (es) 1976-09-16

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE417318B (sv) Forfarande for framstellning av oxofurylesterderivat av penicillin
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE7510790L (sv) Forfarande for framstellning av 2- eller 3-cefemderivat
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE409866B (sv) Forfarande for framstellning av adenosinderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE407061B (sv) Forfarande for framstellning av bensylpyrimidiner
SE387948B (sv) Forfarande for framstellning av tiofen
SE399254B (sv) Forfarande for framstellning av kinazolinonderivat
SE387950B (sv) Forfarande for framstellning av diazaborinderivat
SE384203B (sv) Forfarande for framstellning av 5-hydroxi-1-tetralon